| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0021 | 1 |